IP Library Assignment 055650/0951
Patent Assignment
Reel/Frame 055650/0951

Assignment of Assignor's Interest

Recorded: 2021-03-19 Pages: 16
Assignors
STRUM, JAY COPELAND
Executed: 2021-02-10
BISI, JOHN EMERSON
Executed: 2021-02-10
ROBERTS, PATRICK JOSEPH
Executed: 2021-02-10
Assignee
G1 THERAPEUTICS, INC.
700 PARK OFFICES DRIVE, SUITE 200, RESEARCH TRIANGLE PARK, NORTH CAROLINA, 27709
Covered Properties (33)
Transient Protection of Normal Cells During Chemotherapy
Transient Protection of Hematopoietic Stem and Progenitor Cells Against Ionizing Radiation
Highly Active Anti-Neoplastic and Anti-Proliferative Agents
Hspc-Sparing Treatments for Rb-Positive Abnormal Cellular Proliferation
Transient Protection of Normal Cells During Chemotherapy
Patent: 9,487,530 →
Application: 14/212,430 →
Publication: US 2014/0275066
Transient Protection of Normal Cells During Chemotherapy
Patent: 9,464,092 →
Application: 14/212,911 →
Publication: US 2014/0275067
Transient Protection of Hematopoietic Stem and Progenitor Cells Against Ionizing Radiation
Application: 14/213,382 →
Publication: US 2014/0274896
Highly Active Anti-Neoplastic and Anti-Proliferative Agents
Application: 14/213,784 →
Publication: US 2014/0271460
HSPC-Sparing Treatments for RB-Positive Abnormal Cellular Proliferation
Patent: 9,527,857 →
Application: 14/214,048 →
Publication: US 2014/0271466
Transient Protection of Hematopoietic Stem and Progenitor Cells Against Ionizing Radiation
Application: 14/926,147 →
Publication: US 2016/0045509
Highly Active Anti-Neoplastic and Anti-Proliferative Agents
Application: 15/201,286 →
Publication: US 2016/0310499
Transient Protection of Normal Cells During Chemotherapy
Patent: 9,931,345 →
Application: 15/288,878 →
Publication: US 2017/0037051
Transient Protection of Normal Cells During Chemotherapy
Application: 15/342,990 →
Publication: US 2017/0065597
Transient Protection of Hematopoietic Stem and Progenitor Cells Against Ionizing Radiation
Application: 15/372,269 →
Publication: US 2017/0119774
HSPC-Sparing Treatments for RB-Positive Abnormal Cellular Proliferation
Application: 15/387,083 →
Publication: US 2017/0100405
Highly Active Anti-Neoplastic and Anti-Proliferative Agents
Application: 15/713,385 →
Publication: US 2018/0015096
Transient Protection of Hematopoietic Stem and Progenitor Cells Against Ionizing Radiation
Application: 15/839,685 →
Publication: US 2018/0303838
Transient Protection of Normal Cells During Chemotherapy
Application: 15/943,278 →
Publication: US 2018/0221378
Transient Protection of Normal Cells During Chemotherapy
Application: 16/112,360 →
Publication: US 2018/0360840
Hspc-Sparing Treatments for Rb-Positive Abnormal Cellular Proliferation
Application: 16/112,362 →
Publication: US 2018/0360841
Hspc-Sparing Treatments for Rb-Positive Abnormal Cellular Proliferation
Application: 16/178,419 →
Publication: US 2019/0070185
Highly Active Anti-Neoplastic and Anti-Proliferative Agents
Application: 16/228,308 →
Publication: US 2019/0125752
Transient Protection of Hematopoietic Stem and Progenitor Cells Against Ionizing Radiation
Application: 16/268,317 →
Publication: US 2019/0167691
Transient Protection of Normal Cells During Chemotherapy
Application: 16/886,309 →
Publication: US 2020/0345742
Highly Active Anti-Neoplastic and Anti-Proliferative Agents
Application: 16/926,035 →
Publication: US 2020/0345743
Transient Protection of Hematopoietic Stem and Progenitor Cells Against Ionizing Radiation
Application: 17/102,311 →
Publication: US 2021/0077498
Hspc-Sparing Treatments for Rb-Positive Abnormal Cellular Proliferation
Application: 17/181,638 →
Publication: US 2021/0213022
Transient Protection of Normal Cells During Chemotherapy
Application: 61/798,772 →
Transient Protection of Hematopoietic Stem and Progenitor Cells Against Ionizing Radiation
Application: 61/800,214 →
Pyrazinopyrrolopyrimidines For Use As Anti-Neoplastic Agents
Application: 61/861,374 →
Pyrazinopyrrolopyrimidines For Use As Anti-Neoplastic Agents
Application: 61/911,354 →
HSPC-Sparing Treatments for RB-Positive Abnormal Cellular Proliferation
Application: 61/949,786 →
Highly Active Anti-Neoplastic and Anti-Proliferative Agents
Application: 61/949,795 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 4, 2016
From: STRUM, JAY COPELAND; ROBERTS, PATRICK JOSEPH; BISI, JOHN EMERSON; TAVARES, FRANCIS X.
To: G1 THERAPEUTICS, INC.
Reel/Frame 040221/0433 →
Assignment of Assignor's Interest Dec 20, 2016
From: STRUM, COPELAND, JAY; BISI, JOHN EMERSON; ROBERTS, PARTRICK JOSEPH; TAVARES, FRANCIS XAVIER
To: G1 THERAPEUTICS, INC.
Reel/Frame 041039/0013 →
Assignment of Assignor's Interest Dec 21, 2016
From: STRUM, JAY COPELAND; BISI, JOHN EMERSON; ROBERTS, PATRICK JOSEPH; TAVARES, FRANCIS XAVIER
To: G1 THERAPEUTICS, INC.
Reel/Frame 041153/0637 →
Assignment of Assignor's Interest Jan 25, 2017
From: STRUM, JAY COPELAND; BISI, JOHN EMERSON; ROBERTS, PATRICK JOSEPH; TAVARES, FRANCIS XAVIER
To: G1 THERAPEUTICS, INC.
Reel/Frame 041080/0925 →
Assignment of Assignor's Interest Aug 14, 2018
From: BISI, JOHN EMERSON; ROBERTS, PATRICK JOSEPH; STRUM, JAY COPELAND; TAVARES, FRANCIS X.
To: G1 THERAPEUTICS, INC.
Reel/Frame 046806/0633 →
Assignment of Assignor's Interest Aug 14, 2018
From: TAVARES, FRANCIS XAVIER; BISI, JASON EMERSON; ROBERTS, PATRICK JOSEPH; STRUM, JAY COPELAND
To: G1 THERAPEUTICS, INC.
Reel/Frame 046807/0289 →
Assignment of Assignor's Interest Sep 13, 2018
From: BISI, JOHN EMERSON; ROBERTS, PATRICK JOSEPH; STRUM, JAY COPELAND; TAVARES, FRANCIS X.
To: G1 THERAPEUTICS, INC.
Reel/Frame 046869/0586 →
Assignment of Assignor's Interest May 28, 2019
From: BISI, JOHN EMERSON; ROBERTS, PATRICK JOSEPH; STRUM, JAY COPELAND
To: G1 THERAPEUTICS, INC.
Reel/Frame 049298/0383 →
Assignment of Assignor's Interest May 28, 2019
From: TAVARES, FRANCIS XAVIER
To: G1 THERAPEUTICS, INC.
Reel/Frame 049294/0547 →
Assignment of Assignor's Interest May 28, 2019
From: SHARPLESS, NORMAN E.; BISI, JOHN EMERSON; ROBERTS, PATRICK JOSEPH; STRUM, JAY COPELAND
To: G1 THERAPEUTICS, INC.
Reel/Frame 049294/0574 →
Assignment of Assignor's Interest May 28, 2019
From: SHARPLESS, NORMAN E.; BISI, JOHN EMERSON; ROBERTS, PATRICK JOSEPH; STRUM, JAY COPELAND
To: G1 THERAPEUTICS, INC.
Reel/Frame 049294/0627 →
Assignment of Assignor's Interest May 28, 2019
From: SHARPLESS, NORMAL E.; BISI, JOHN EMERSON; ROBERTS, PATRICK JOSEPH; STRUM, JAY COPELAND
To: G1 THERAPEUTICS, INC.
Reel/Frame 049294/0739 →
Assignment of Assignor's Interest May 28, 2019
From: SHARPLESS, NORMAN E.
To: G1 THERAPEUTICS, INC.
Reel/Frame 049294/0198 →
Assignment of Assignor's Interest Mar 10, 2020
From: SHARPLESS, NORMAN E.; BISI, JOHN EMERSON; ROBERTS, PATRICK JOSEPH; STRUM, JAY COPELAND
To: G1 THERAPEUTICS, INC.
Reel/Frame 052073/0354 →
Assignment of Assignor's Interest Mar 10, 2020
From: SHARPLESS, NORMAN E.; BISI, JOHN EMERSON; ROBERTS, PATRICK JOSEPH; STRUM, JAY COPELAND
To: G1 THERAPEUTICS, INC.
Reel/Frame 052137/0310 →
Assignment of Assignor's Interest Mar 10, 2020
From: SHARPLESS, NORMAN E.; BISI, JOHN EMERSON; ROBERTS, PATRICK JOSEPH; STRUM, JAY COPELAND
To: G1 THERAPEUTICS, INC.
Reel/Frame 052073/0315 →
Assignment of Assignor's Interest Mar 10, 2020
From: SHARPLESS, NORMAN E.; BISI, JOHN EMERSON; ROBERTS, PATRICK JOSEPH; STRUM, JAY COPELAND
To: G1 THERAPEUTICS, INC.
Reel/Frame 052073/0415 →
Assignment of Assignor's Interest Mar 10, 2020
From: SHARPLESS, NORMAN E.; BISI, JOHN EMERSON; ROBERTS, PATRICK JOSEPH; STRUM, JAY COPELAND
To: G1 THERAPEUTICS, INC.
Reel/Frame 052137/0273 →
Assignment of Assignor's Interest Mar 10, 2020
From: SHARPLESS, NORMAL E.; BISI, JOHN EMERSON; ROBERTS, PATRICK JOSEPH; STRUM, JAY COPELAND
To: G1 THERAPEUTICS, INC.
Reel/Frame 052073/0387 →
Assignment of Assignor's Interest Mar 10, 2020
From: SHARPLESS, NORMAN E.; BISI, JOHN EMERSON; ROBERTS, PATRICK JOSEPH; STRUM, JAY COPELAND
To: G1 THERAPEUTICS, INC.
Reel/Frame 052073/0400 →
Assignment of Assignor's Interest Mar 10, 2020
From: SHARPLESS, NORMAN E.; BISI, JOHN EMERSON; ROBERTS, PATRICK JOSEPH; STRUM, JAY COPELAND
To: G1 THERAPEUTICS, INC.
Reel/Frame 052073/0369 →
Corrective Assignment to Correct the Property Number Previously Recorded at Reel: 52073 Frame: 354. Assignor(S) Hereby Confirms the Assignment. Apr 1, 2020
From: SHARPLESS, NORMAN E.; BISI, JOHN EMERSON; ROBERTS, PATRICK JOSEPH; STRUM, JAY COPELAND
To: C4 THERAPEUTICS, INC.
Reel/Frame 052283/0370 →
Corrective Assignment to Correct the First Assignor's Execution Date Previously Recorded at Reel: 052073 Frame: 0315. Assignor(S) Hereby Confirms the Assignment. Apr 1, 2020
From: SHARPLESS, NORMAL E.; BISI, JOHN EMERSON; ROBERTS, PATRICK JOSEPH; STRUM, JAY COPELAND
To: C4 THERAPEUTICS, INC.
Reel/Frame 052283/0380 →
Corrective Assignment to Correct the Application Number 16112362 Previously Recorded on Reel 052137 Frame 0310. Assignor(S) Hereby Confirms the Assignment. Apr 1, 2020
From: SHARPLESS, NORMAN E.; BISI, JOHN EMERSON; ROBERTS, PATRICK JOSEPH; STRUM, JAY COPELAND
To: C4 THERAPEUTICS, INC.
Reel/Frame 052283/0389 →
Corrective Assignment to Correct the Property Number Previously Recorded at Reel: 52073 Frame: 369. Assignor(S) Hereby Confirms the Assignment. Apr 1, 2020
From: SHARPLESS, NORMAN E.; BISI, JOHN EMERSON; ROBERTS, PATRICK JOSEPH; STRUM, JAY COPELAND
To: C4 THERAPEUTICS, INC.
Reel/Frame 052283/0401 →